• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Topics » Infection » Coronavirus

Coronavirus
Coronavirus RSS Feed RSS

Other news to note for March 15, 2021

March 15, 2021
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Daxor, Decipher Biosciences, Firstsource Solutions, Intellih, Invo Bioscience, Lygos, Maravai Lifesciences, Microbix Biosystems, Peridot, Protoquick, Seegene Canada, Seisa Medical, Quest Diagnostics, Trilink Biotechnologies, Twist Bioscience, Veracyte, Zora Biosciences.
Read More

Canadian company to J&J: License, or else. . . .

March 15, 2021
By Mari Serebrov
While World Trade Organization members continue to debate a proposal to waive intellectual property rights for COVID-19 vaccines and therapies, Biolyse Pharma Corp. is threatening to apply for a compulsory license of Johnson & Johnson’s one-dose vaccine through the Canadian Access to Medicines Regime.
Read More

Vaccine misinformation campaign a ‘dangerous precedent’

March 15, 2021
By Mari Serebrov
After working 24/7 to develop a COVID-19 vaccine in a historic timeframe and scale up manufacturing at an unprecedented rate, some vaccine manufacturers are now facing what appears to be a concerted Russian misinformation campaign akin to those used in the last two U.S. presidential campaigns, as well as in Great Britain and possibly in France.
Read More

Clinical data up 30% over last year; a fifth focused on COVID-19

March 15, 2021
By Karen Carey
After a year of intense biopharma research, an increasing arsenal of answers is bolstering the fight against COVID-19.
Read More

Kintor’s proxalutamide reduces COVID-19 mortality risk by 92%; trial in ICU patients next

March 15, 2021
By Elise Mak
Kintor Pharmaceutical Ltd. said its androgen receptor (AR) antagonist, proxalutamide, reduced mortality risk by 92% and shortened median hospital length stay by nine days vs. standard of care, based on a preliminary analysis of phase III data from 590 hospitalized COVID-19 patients in Brazil. The company expects to have final data ready by the end of this month or early April, Chief Financial Officer Lucy Lu told BioWorld. Following the positive results, Kintor is seeking conditional approval in Brazil and will start another trial in critically ill patients in intensive care, she said.
Read More

Other news to note for March 15, 2021

March 15, 2021
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adamis, Aeterna Zentaris, Altimmune, Amring, Amzell, Aveo, Astrazeneca, Biovaxys, Bright Minds, Decipher, Destiny, Genevant, Gilead, Horizon, J&J, Lattice, Magenta, Merck, Mersana, Newron, Point, PTC, Resverlogix, Takeda, Tevogen, Timber, Urogen, Veracyte, Viela, Wuxi, Zambon.
Read More

In the clinic for March 15, 2021

March 15, 2021
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aclaris, Amgen, Atara, Atyr, Bioaegis, Bioarctic, Black Diamond, Bluebird, Corcept, Curasen, Edesa, Eisai, Equillium, Galecto, Gamida, Immunitybio, Lilly, Magenta, Moderna, Molecular Partners, Novartis, Ocuphire, Opthea, Ose, Quantum Leap, Regeneron, Rubius, Sernova, Takeda, Tilt, Timber, Tonix, Zenith.
Read More
Map of Europe, France filled in with French flag

French health care companies have doubled sales revenues in five years

March 12, 2021
By Bernard Banga
According to the latest annual overview published by trade association France Biotech, French med-tech, biotech, and e-health companies have adapted rapidly to the COVID-19 pandemic. Many French health care companies have faced real difficulties in all areas of procurement, R&D, and sales. As of February, a quarter of these French companies were redirecting their research activity towards the coronavirus.
Read More
U.S. FDA headquarters

Compliance sticker shock may await EUA holders new to device space

March 12, 2021
By Mark McCarty
Most of the med-tech companies doing business during the COVID-19 pandemic are experienced and already have their FDA compliance systems in place. However, Dennis Gucciardo, a partner at the D.C. office of Morgan, Lewis & Bockius LLP, told BioWorld that while the FDA will give industry sufficient time to transition their emergency use authorizations (EUAs) to conventional premarket filings, the cost of setting up a quality management system may be greater than some current EUA holders are willing to bear.
Read More

Other news to note for March 12, 2021

March 12, 2021
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aino Health, Bps Bioscience, Wihuri Oy.
Read More
Previous 1 2 … 261 262 263 264 265 266 267 268 269 … 548 549 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 11, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 11, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 8, 2025
  • Incurix describes new c-Myc inhibitors

    BioWorld Science
    Incurix Co. Ltd. has identified Myc proto-oncogene protein (c-Myc) inhibitors reported to be useful for the treatment of cancer.
  • 3D rendering of a molecular glue mediating the interaction between two proteins

    With surface mimicry, molecular glues shed hairpin need

    BioWorld Science
    Degradation is a therapeutic strategy that could offer possibilities to get at currently undruggable target proteins. In targeted degradation, compounds induce...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe